Funded Tech Companies
Aptimmune Biologics
Aptimmune Biologics, based in St. Louis, received equity investments from private investors and Arsenal Capital Partners.
Company Overview
Company Name
Aptimmune Biologics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1005 N. Warson Rd.
St. Louis, MS 63132
USA
St. Louis, MS 63132
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Aptimmune Biologics specializes in developing revolutionary mucosal vaccines that provide unsurpassed efficacy against the viral diseases most costly to the swine industry. We focus solely on swine vaccines and the prevention of two major diseases -- Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/12/2017
Financing History
Management Team
Title
Name
Email & Social
Chairman
Robert Nordgren
Chief Executive Officer
Heather Bessoff
Chief Scientific Officer
Federico Zuckermann
VP - Marketing
Andrew Smythe
Company Investors
- Arsenal Capital Partners
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs